vs
Side-by-side financial comparison of INNEOVA Holdings Ltd (INEO) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
Quipt Home Medical Corp. is the larger business by last-quarter revenue ($49.0M vs $30.8M, roughly 1.6× INNEOVA Holdings Ltd). INNEOVA Holdings Ltd runs the higher net margin — 0.8% vs -2.1%, a 2.9% gap on every dollar of revenue. Quipt Home Medical Corp. produced more free cash flow last quarter ($6.9M vs $-1.5M).
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
INEO vs QIPT — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $30.8M | $49.0M |
| Net Profit | $243.0K | $-1.1M |
| Gross Margin | 19.3% | 53.5% |
| Operating Margin | 3.6% | 2.1% |
| Net Margin | 0.8% | -2.1% |
| Revenue YoY | — | 32.3% |
| Net Profit YoY | — | 2.9% |
| EPS (diluted) | $0.02 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $49.0M | ||
| Q3 25 | — | $39.8M | ||
| Q2 25 | $30.8M | $35.1M | ||
| Q1 25 | — | $33.3M | ||
| Q4 24 | — | $37.1M |
| Q4 25 | — | $-1.1M | ||
| Q3 25 | — | $-3.5M | ||
| Q2 25 | $243.0K | $-3.0M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | — | $-1.1M |
| Q4 25 | — | 53.5% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | 19.3% | 57.6% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | — | 52.1% |
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | -3.6% | ||
| Q2 25 | 3.6% | -5.2% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | — | 1.2% |
| Q4 25 | — | -2.1% | ||
| Q3 25 | — | -8.9% | ||
| Q2 25 | 0.8% | -8.6% | ||
| Q1 25 | — | -9.1% | ||
| Q4 24 | — | -2.9% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | $0.02 | $-0.07 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.1M | $10.5M |
| Total DebtLower is stronger | $2.9M | $84.0M |
| Stockholders' EquityBook value | $11.2M | $113.0M |
| Total Assets | $52.6M | $280.7M |
| Debt / EquityLower = less leverage | 0.26× | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.5M | ||
| Q3 25 | — | $12.9M | ||
| Q2 25 | $2.1M | $11.3M | ||
| Q1 25 | — | $17.1M | ||
| Q4 24 | — | $15.5M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | $2.9M | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M |
| Q4 25 | — | $113.0M | ||
| Q3 25 | — | $112.1M | ||
| Q2 25 | $11.2M | $102.5M | ||
| Q1 25 | — | $103.6M | ||
| Q4 24 | — | $106.3M |
| Q4 25 | — | $280.7M | ||
| Q3 25 | — | $283.3M | ||
| Q2 25 | $52.6M | $236.1M | ||
| Q1 25 | — | $244.6M | ||
| Q4 24 | — | $242.8M |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | 0.26× | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-301.0K | $8.9M |
| Free Cash FlowOCF − Capex | $-1.5M | $6.9M |
| FCF MarginFCF / Revenue | -4.8% | 14.0% |
| Capex IntensityCapex / Revenue | 3.8% | 4.2% |
| Cash ConversionOCF / Net Profit | -1.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.9M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | $-301.0K | $9.7M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | — | $9.3M |
| Q4 25 | — | $6.9M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | $-1.5M | $4.4M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $5.6M |
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | -4.8% | 12.6% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 15.2% |
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | 3.8% | 14.9% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 9.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
